Detalhe da pesquisa
1.
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity.
Blood
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38635762
2.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35660812
3.
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial.
Br J Haematol
; 204(4): 1429-1438, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38348544
4.
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
Br J Haematol
; 204(3): 887-891, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38054558
5.
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
Blood
; 139(9): 1330-1339, 2022 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34570879
6.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38721749
7.
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.
Am J Hematol
; 99(5): 880-889, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38504387
8.
Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation.
Am J Hematol
; 98(6): 940-950, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37052167
9.
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
Am J Hematol
; 98(1): 140-147, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35567778
10.
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?
Br J Haematol
; 197(3): 326-338, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35286719
11.
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.
Haematologica
; 107(5): 1045-1053, 2022 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34382386
12.
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials.
Cytotherapy
; 24(7): 742-749, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35219582
13.
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
Blood
; 133(7): 754-762, 2019 02 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30545834
14.
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?
Biol Blood Marrow Transplant
; 26(4): e77-e85, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31917272
15.
Myeloablative versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis.
Biol Blood Marrow Transplant
; 26(6): e138-e141, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32171885
16.
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.
Biol Blood Marrow Transplant
; 26(12): 2229-2236, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32920204
17.
Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.
Biol Blood Marrow Transplant
; 26(11): 2011-2017, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32717431
18.
Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them.
Biol Blood Marrow Transplant
; 26(7): 1288-1297, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32135202
19.
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
Biol Blood Marrow Transplant
; 26(5): 893-901, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31982543
20.
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation.
Biol Blood Marrow Transplant
; 26(9): 1670-1678, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32562858